Nuclear medical inpatient treatment in Germany analysis of the structured quality reports 2004 to 2008;Stationäre nukleaimedizinische Therapie in Deutschland -Analyse der strukturierten Qualitätsberichte 2004 bis 2008

NuklearMedizin

Volumn 49, Issue 2, 2010, Pages 49-57

  Lorenz, R ^a   Dietlein, M ^b   Reiners, C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Inpatient treatment; Nuclear medicine; Numerical data; Radioiodine therapy; Utilization review; Utilization statistics

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; GERMANY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; NUCLEAR MEDICINE; RADIOISOTOPE THERAPY; THYROID CANCER; ADULT; HOSPITAL SUBDIVISIONS AND COMPONENTS; STANDARD; STATISTICS;

ADULT; GERMANY; HOSPITAL UNITS; HUMANS; HYPERTHYROIDISM; INPATIENTS; NUCLEAR MEDICINE; QUALITY ASSURANCE, HEALTH CARE;

EID: 77950788195     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0296     Document Type: Article

References (41)

1. Bachmann J, Kobe C, Bor S et al. Radioiodine therapy for thyroid volume reduction of large goitres. Nucl Med Commun 2009; 30: 466-471.
2. Bennedbaek FN, Hegedus L. Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 2000; 85: 2493-2498. (Pubitemid 32269206)
3. Bennedbaek FN, Ferrild H, Hegedus L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf ) 1999; 50: 357-363.
4. Bergenfelz A, Jansson S, Kristoffersson A et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3, 660 patients. Langenbecks Arch Surg 2008; 393: 667-673.
5. Bonnema SJ, Bennedbaek FN, Ladenson PW, Hegedus L. Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 2002; 87:112-117.
6. Bonnema SJ, Bennedbaek FN, Wiersinga WM, Hegedus L. Management of the nontoxic multinodular goitre: A European questionnaire study. Clin Endocrinol (Oxf) 2000; 53:5-12. (Pubitemid 30646121)
7. Bulow Pedersen I, Knudsen N, Jorgensen T et al. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative registerbased population survey. J Clin Endocrinol Metab 2002; 87: 4462-4469. (Pubitemid 35247026)
8. Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
9. Deutsche Krankenhausgesellschaft (DKG), GKVSpitzenverband, Verband der Privaten Krankenversicherung (FKV), Institut für das Entgeltsystem im Krankenhaus (InEK Gmbh). Deutsche Kodierrichtlinien Version 2010. Siegburg: Institut für das Entgeltsystem im Krankenhaus (InEK GmbH) 2009.
10. Diehl LA, Garcia V, Bonnema SJ et al. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. J Clin Endocrinol Metab 2005; 90: 117-123. (Pubitemid 40116643)
11. Dietlein M, Dederichs B, Kobe C et al. Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery. Nuklearmedizin 2006; 45: 21-34. (Pubitemid 44070818)
12. Dietlein M, Dressler J, Eschner W et al. Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3). Nuklearmedizin 2007; 46: 213-219. (Pubitemid 47612288)
13. Dietlein M, Dressier J, Eschner W et al. Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3). Nuklearmedizin 2007; 46: 206-212. (Pubitemid 47612287)
14. Dietlein M, Wegscheider K, Vaupel R et al. Management of multinodular goiter in Germany (Papillon 2005): Do the approaches of thyroid specialists and primary care practitioners differ? Nuklearmedizin 2007; 46: 65-75.
15. Dietlein M, Wegscheider K, Vaupel Retal. Survey of management of solitary thyroid nodules in Germany. Nuklearmedizin 2008; 47: 87-96. (Pubitemid 351881402)
16. Döbert N, Balzer K, Diener J et al Thyroid sonomorphology, thyroid peroxidase antibodies and thyroid function: new epidemiological data in unselected German employees. Nuklearmedizin 2008; 47: 194-199.
17. Dralle H, Sekulla C, Haerting J et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004; 136: 1310-1322. (Pubitemid 39647550)
18. Gärtner R. Arbeitskreis IodmangeL 25 Jahre Aufklärung Über den Iodmangel - Erfolgreiche Verbraucherbildung und Gesundheitsvorsorge. In: 39. Jahrestagung der Sektion Schilddrüse der Deut sehen Gesellschaft für Endokrinologie. Stuttgart; 2009: 37-40.
19. GenzymeGmbH(Hrsg).Der Kliniklotse Radioiodtherapie. Stuttgart: Ligatur 2009.
20. Hensen P, Roeder N. Strukturierter Qualitätsbericht. In: Roeder N, Rochell B (eds). Case-Mix in der Praxis. Köln: Deutscher Ärzte-Verlag; 2007: 15. 12 1-23.
21. Kobe C, Eschner W, Sudbrock F et al. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy? Nuklearmedizin 2008; 47: 13-17.
22. Kobe C, Weber I, Eschner W et al. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication? Nuklearmedizin 2008; 47: 153-156.
23. Krohn T, Meyer PT, Ocklenburg C et al. Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance. Nuklearmedizin 2008; 47: 248-254
24. Laurberg P, Jorgensen T, Perrild H et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol 2006; 155: 219-228. (Pubitemid 44269438)
25. Lindner O, Burchert W, Bengel FM et al. Myocardial perfusion scintigraphy 2007 in Germany- results of the query and current status. Nuklearmedizin 2009; 48: 131-137.
26. Luster M, Clarke SE, Dietlein M et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2008; 35: 1941-1959.
27. Pacini F, Schlumberger M, Dralle H et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154; 787-803. (Pubitemid 43997716)
28. Rahbar K, Hutzenlaub V, Fischer RJ et al. Risk-profile and outcome of small papillary and follicular thyroid carcinomas (
29. Reiners C, Dietlein M, Luster M. Malignant goiter thyroid cancer. Dtsch Med Wochenschr 2008; 133: 2215-2228.
30. Reiners C, Dietlein M, Luster M. Radio-iodine therapy in differentiated thyroid cancer: indications and procedures. Best Pract Res Clin Endocrinol Metab 2008; 22:989-1007.
31. Rosato L, Avenia N, Bernante P et al. Complications of thyroid surgery: analysis of a multicentric study on 14934 patients operated on in Italy over 5 years. World J Surg 2004; 28: 271-276. (Pubitemid 38375527)
32. Schicha H, Hellmich M, Lehmacher W et al. Should all patients with thyroid nodules > or = 1 cm undergo fine-needle aspiration biopsy?. Nuklearmedizin 2009; 48: 79-83.
33. Schomäcker K, Dietlein M, Schnell R et al. Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives. Nuklearmedizin 2005; 44: 166-177.
34. Scott-Coombes D. British Association of Endocrine Surgeons, Second national audit report 2007. Henley-on-Thames, UK, 2007.
35. Spilker L, Happel C, Dobert N, Grünwald F. Is radioiodine therapy conducted too late in patients suffering from thyroid autonomy?. Nuklearmedizin 2008; 47: 8-12. (Pubitemid 351272804)
36. Statistische Ämter des Bundes und der Länder. Gebiet und Bevölkerung - Fläche und Bevölkerung. www.statistik-portal.de/ Statistik-Portal/
37. Statististisches Bundesamt (Hrsg). Gesundheit Grunddaten der Krankenhäuser - Fachserie 12 Reihe 6.1.1 - 2008. Wiesbaden: Statistisches Bundesamt 2009.
38. Theissen P, Schmidt M, IvanovaTet al. MIBI scintigraphy in hypofunctioning thyroid nodules - can it predict the dignity of the lesion? Nuklearmedizin 2009; 48: 144-152.
39. Vejbjerg P, Knudsen N, Perrild H et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf) 2009; 71: 440-445.
40. Verburg FA, de Keizer B, de Klerk JM et al. Value of diagnostic radioiodine scintigraphy and thyroglobulin measurements after rhTSH injection. Nuklearmedizin 2009; 48: 26-29.
41. Klinikführer Berlin 2009. Berlin: Der Tagesspiegel GmbH 2009.